0001779436-21-000001.txt : 20211213 0001779436-21-000001.hdr.sgml : 20211213 20211210190457 ACCESSION NUMBER: 0001779436-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211213 DATE AS OF CHANGE: 20211210 EFFECTIVENESS DATE: 20211213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMyx Therapeutics, Inc. CENTRAL INDEX KEY: 0001779436 IRS NUMBER: 832289356 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-424596 FILM NUMBER: 211486624 BUSINESS ADDRESS: STREET 1: 445 N 5TH ST CITY: PHOENIX STATE: AZ ZIP: 85004 BUSINESS PHONE: (858) 945-2703 MAIL ADDRESS: STREET 1: 445 N 5TH ST CITY: PHOENIX STATE: AZ ZIP: 85004 D 1 primary_doc.xml X0708 D LIVE 0001779436 OncoMyx Therapeutics, Inc. 850 N. 5th St., Ste. 402 PHOENIX AZ ARIZONA 85004 (602) 567-8064 DELAWARE None None Corporation true 2018 Steven J. Potts, Ph.D. 850 N. 5th St., Ste. 402 Phoenix AZ ARIZONA 85004 Executive Officer Director Kanad Das, Ph.D. 850 N. 5th St., Ste. 402 Phoenix AZ ARIZONA 85004 Director Ting Xiao, C.F.A., F.R.M. 850 N. 5th St., Ste. 402 Phoenix AZ ARIZONA 85004 Director Benjamin Rovinski, Ph.D. 850 N. 5th St., Ste. 402 Phoenix AZ ARIZONA 85004 Director Widya Mulyasasmita, Ph.D. 850 N. 5th St., Ste. 402 Phoenix AZ ARIZONA 85004 Director Charles M. Baum, M.D., Ph.D. 850 N. 5th St., Ste. 402 Phoenix AZ ARIZONA 85004 Director Leslie Sharp, Ph.D. 850 N. 5th St., Ste. 402 Phoenix AZ ARIZONA 85004 Executive Officer Biotechnology Decline to Disclose 06b false 2021-11-19 false true false 0 50000000 50000000 0 false 13 0 0 0 false OncoMyx Therapeutics, Inc. /s/Steven J. Potts, Ph.D. Steven J. Potts, Ph.D. President and Chief Executive Officer 2021-12-10